Overview Financials News + Filings Key Docs Charts Ownership Insiders |
Harpoon Therapeutics, Inc. (HARP)
|
Add to portfolio |
|
|
Price: |
$8.02
| | Metrics |
OS: |
38.8
|
M
| |
-1345
|
% ROE
|
Market cap: |
$311
|
M
| |
-554
|
% ROIC
|
Net cash:
|
$32.8
|
M
| |
$0.85
|
per share
|
EV:
|
$278
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
($34.9)
|
M
| |
|
|
EBIT
|
($37.1)
|
M
| |
|
|
EPS |
($1.19)
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-05-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
Revenues | 31.9 | 23.7 | 23.7 | 17.4 | 5.8 | 4.8 | 0.7 | 0.0 |
Revenue growth | 34.9% | 35.6% | | 202.0% | 21.6% | 570.9% | | |
Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross profit | 31.9 | 23.7 | 23.7 | 17.4 | 5.8 | 4.8 | 0.7 | 0.0 |
Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
Selling, general and administrative | 100.2 | 140.4 | | 68.8 | 64.0 | 32.5 | 17.2 | 11.1 |
General and administrative | | | 18.3 | | | | | |
EBIT | -68.3 | -116.8 | -66.8 | -51.3 | -58.2 | -27.7 | -16.5 | 0.0 |
EBIT margin | -214.1% | -493.6% | -282.4% | -294.3% | -1007.5% | -583.7% | -2334.5% | |
Pre-tax income | -67.7 | -116.7 | -116.7 | -49.9 | -55.6 | -27.4 | -16.8 | -11.4 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -67.7 | -116.7 | -116.7 | -49.9 | -55.6 | -27.4 | -16.8 | -11.4 |
Net margin | -212.2% | -493.5% | -493.5% | -286.1% | -962.0% | -576.1% | -2377.1% | |
|
Diluted EPS | ($2.04) | ($3.62) | ($3.62) | ($1.99) | ($2.56) | ($25.65) | ($18.81) | ($21.61) |
Shares outstanding (diluted) | 33.2 | 32.3 | 32.3 | 25.0 | 21.7 | 1.1 | 0.9 | 0.5 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|